Last 12 months
Inside the activity.
1 purchase rows · 42 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 12 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 11 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 5 |
| Jun 2026 | 0 | 3 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 1 | 6 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 02, 2023 Filed Aug 4, 2023 23:10 UTC |
Perez Jeffrey ThomasSVP, IP Affairs
|
Exercise / conversionRestricted Stock Unit · Derivative | 18,878 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-23-011614 · dp198067_4-perez.xml · derivative · entry 3 Perez Jeffrey Thomas · CIK 0001617812 · SVP, IP Affairs 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,634 Underlying: Common Stock · 18,878 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F3 · derivative.exercise_date: Represents 1/6 of the RSUs granted on March 24, 2023 that vested on August 2, 2023. The remaining RSUs vest in three equal installments on each of August 9, 2023, August 16, 2023 and August 23, 2023. F3 · derivative.expiration_date: Represents 1/6 of the RSUs granted on March 24, 2023 that vested on August 2, 2023. The remaining RSUs vest in three equal installments on each of August 9, 2023, August 16, 2023 and August 23, 2023. Read SEC document |
| August 02, 2023 Filed Aug 4, 2023 23:10 UTC |
Perez Jeffrey ThomasSVP, IP Affairs
|
Exercise / conversionCommon Stock | 18,878 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-23-011614 · dp198067_4-perez.xml · nonDerivative · entry 1 Perez Jeffrey Thomas · CIK 0001617812 · SVP, IP Affairs 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 437,646 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. Read SEC document |
| August 02, 2023 Filed Aug 4, 2023 23:09 UTC |
Lehr Donald P.Chief Legal Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 21,710 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-23-011613 · dp198068_4-lehr.xml · derivative · entry 3 Lehr Donald P. · CIK 0001583187 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 65,130 Underlying: Common Stock · 21,710 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F3 · derivative.exercise_date: Represents 1/6 of the RSUs granted on March 24, 2023 that vested on August 2, 2023. The remaining RSUs vest in three equal installments on each of August 9, 2023, August 16, 2023 and August 23, 2023. F3 · derivative.expiration_date: Represents 1/6 of the RSUs granted on March 24, 2023 that vested on August 2, 2023. The remaining RSUs vest in three equal installments on each of August 9, 2023, August 16, 2023 and August 23, 2023. Read SEC document |
| August 02, 2023 Filed Aug 4, 2023 23:09 UTC |
Lehr Donald P.Chief Legal Officer
|
Exercise / conversionCommon Stock | 21,710 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-23-011613 · dp198068_4-lehr.xml · nonDerivative · entry 1 Lehr Donald P. · CIK 0001583187 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 407,342 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. Read SEC document |
| August 02, 2023 Filed Aug 4, 2023 23:05 UTC |
Sabzevari HelenDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 141,587 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-23-011610 · dp198085_4-sabzevari.xml · derivative · entry 3 Sabzevari Helen · CIK 0001724195 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 424,760 Underlying: Common Stock · 141,587 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F3 · derivative.exercise_date: Represents 1/6 of the RSUs granted on March 24, 2023 that vested on August 2, 2023. The remaining RSUs vest in three equal installments on each of August 9, 2023, August 16, 2023 and August 23, 2023. F3 · derivative.expiration_date: Represents 1/6 of the RSUs granted on March 24, 2023 that vested on August 2, 2023. The remaining RSUs vest in three equal installments on each of August 9, 2023, August 16, 2023 and August 23, 2023. Read SEC document |
| August 02, 2023 Filed Aug 4, 2023 23:05 UTC |
Sabzevari HelenDirector · President and CEO
|
Exercise / conversionCommon Stock | 141,587 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-23-011610 · dp198085_4-sabzevari.xml · nonDerivative · entry 1 Sabzevari Helen · CIK 0001724195 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,362,373 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. Read SEC document |
| April 28, 2023 Filed May 2, 2023 21:57 UTC |
Shah Rutul RChief Operating Officer
|
GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 500,000 | $0.00 Strike: $1.21 | $0.00 |
DisclosureSEC source: 0000950103-23-006765 · dp193271_4-shah.xml · derivative · entry 1 Shah Rutul R · CIK 0001947221 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2033-04-28 F1 · derivative.exercise_date: The options vest 25% on April 28, 2024 and in equal monthly installments for three years thereafter. Read SEC document |
| April 28, 2023 Filed May 2, 2023 21:47 UTC |
Thomasian Harry Jr.Chief Financial Officer
|
GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 521,000 | $0.00 Strike: $1.21 | $0.00 |
DisclosureSEC source: 0000950103-23-006760 · dp193268_4-thomasian.xml · derivative · entry 1 Thomasian Harry Jr. · CIK 0001886301 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 521,000 Underlying: Common Stock · 521,000 shares Expires 2033-04-28 F1 · derivative.exercise_date: The options vest 25% on April 28, 2024 and in equal monthly installments for three years thereafter. Read SEC document |
| April 28, 2023 Filed May 2, 2023 21:53 UTC |
Sabzevari HelenDirector · President and CEO
|
GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 1,732,300 | $0.00 Strike: $1.21 | $0.00 |
DisclosureSEC source: 0000950103-23-006763 · dp193270_4-sabzevari.xml · derivative · entry 1 Sabzevari Helen · CIK 0001724195 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,732,300 Underlying: Common Stock · 1,732,300 shares Expires 2033-04-28 F1 · derivative.exercise_date: The options vest 25% on April 28, 2024 and in equal monthly installments for three years thereafter. Read SEC document |
| April 28, 2023 Filed May 2, 2023 21:43 UTC |
Perez Jeffrey ThomasSVP, IP Affairs
|
GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $1.21 | $0.00 |
DisclosureSEC source: 0000950103-23-006759 · dp193267_4-perez.xml · derivative · entry 1 Perez Jeffrey Thomas · CIK 0001617812 · SVP, IP Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2033-04-28 F1 · derivative.exercise_date: The options vest 25% on April 28, 2024 and in equal monthly installments for three years thereafter. Read SEC document |
| April 28, 2023 Filed May 2, 2023 21:50 UTC |
Lehr Donald P.Chief Legal Officer
|
GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $1.21 | $0.00 |
DisclosureSEC source: 0000950103-23-006761 · dp193269_4-lehr.xml · derivative · entry 1 Lehr Donald P. · CIK 0001583187 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2033-04-28 F1 · derivative.exercise_date: The options vest 25% on April 28, 2024 and in equal monthly installments for three years thereafter. Read SEC document |
| March 24, 2023 Filed Mar 29, 2023 01:12 UTC |
Shah Rutul RChief Operating Officer
|
GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 40,409 | $0.00 Strike: $0.96 | $0.00 |
DisclosureSEC source: 0000950103-23-004827 · dp191373_4-shah.xml · derivative · entry 4 Shah Rutul R · CIK 0001947221 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,409 Underlying: Common Stock · 40,409 shares Expires 2033-03-24 Read SEC document |
| March 24, 2023 Filed Mar 29, 2023 01:12 UTC |
Shah Rutul RChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 30,960 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-23-004827 · dp191373_4-shah.xml · derivative · entry 3 Shah Rutul R · CIK 0001947221 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,920 Underlying: Common Stock · 30,960 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F3 · derivative.exercise_date: Represents 1/3 of the RSUs granted on March 24, 2023 that vested immediately. F3 · derivative.expiration_date: Represents 1/3 of the RSUs granted on March 24, 2023 that vested immediately. Read SEC document |
| March 24, 2023 Filed Mar 29, 2023 01:12 UTC |
Shah Rutul RChief Operating Officer
|
GrantRestricted Stock Units · Derivative | 92,880 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-23-004827 · dp191373_4-shah.xml · derivative · entry 2 Shah Rutul R · CIK 0001947221 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,880 Underlying: Common Stock · 92,880 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F2 · derivative.exercise_date: 1/3 of the RSUs vested immediately upon the grant date, and the remaining RSUs vest in four equal installments on each of August 2, 2023, August 9, 2023, August 16, 2023 and August 23, 2023. F2 · derivative.expiration_date: 1/3 of the RSUs vested immediately upon the grant date, and the remaining RSUs vest in four equal installments on each of August 2, 2023, August 9, 2023, August 16, 2023 and August 23, 2023. Read SEC document |
| March 24, 2023 Filed Mar 29, 2023 01:12 UTC |
Shah Rutul RChief Operating Officer
|
Exercise / conversionCommon Stock | 30,960 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-23-004827 · dp191373_4-shah.xml · nonDerivative · entry 1 Shah Rutul R · CIK 0001947221 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,997 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. Read SEC document |
| March 24, 2023 Filed Mar 29, 2023 01:12 UTC |
Thomasian Harry Jr.Chief Financial Officer
|
GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 46,815 | $0.00 Strike: $0.96 | $0.00 |
DisclosureSEC source: 0000950103-23-004828 · dp191374_4-thomasian.xml · derivative · entry 4 Thomasian Harry Jr. · CIK 0001886301 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,815 Underlying: Common Stock · 46,815 shares Expires 2033-03-24 Read SEC document |
| March 24, 2023 Filed Mar 29, 2023 01:12 UTC |
Thomasian Harry Jr.Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 35,868 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-23-004828 · dp191374_4-thomasian.xml · derivative · entry 3 Thomasian Harry Jr. · CIK 0001886301 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,737 Underlying: Common Stock · 35,868 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F3 · derivative.exercise_date: Represents 1/3 of the RSUs granted on March 24, 2023 that vested immediately. F3 · derivative.expiration_date: Represents 1/3 of the RSUs granted on March 24, 2023 that vested immediately. Read SEC document |
| March 24, 2023 Filed Mar 29, 2023 01:12 UTC |
Thomasian Harry Jr.Chief Financial Officer
|
GrantRestricted Stock Units · Derivative | 107,605 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-23-004828 · dp191374_4-thomasian.xml · derivative · entry 2 Thomasian Harry Jr. · CIK 0001886301 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,605 Underlying: Common Stock · 107,605 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F2 · derivative.exercise_date: 1/3 of the RSUs vested immediately upon the grant date, and the remaining RSUs vest in four equal installments on each of August 2, 2023, August 9, 2023, August 16, 2023 and August 23, 2023. F2 · derivative.expiration_date: 1/3 of the RSUs vested immediately upon the grant date, and the remaining RSUs vest in four equal installments on each of August 2, 2023, August 9, 2023, August 16, 2023 and August 23, 2023. Read SEC document |
| March 24, 2023 Filed Mar 29, 2023 01:12 UTC |
Thomasian Harry Jr.Chief Financial Officer
|
Exercise / conversionCommon Stock | 35,868 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-23-004828 · dp191374_4-thomasian.xml · nonDerivative · entry 1 Thomasian Harry Jr. · CIK 0001886301 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,829 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. Read SEC document |
| March 24, 2023 Filed Mar 29, 2023 01:10 UTC |
Perez Jeffrey ThomasSVP, IP Affairs
|
GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 49,279 | $0.00 Strike: $0.96 | $0.00 |
DisclosureSEC source: 0000950103-23-004826 · dp191372_4-perez.xml · derivative · entry 4 Perez Jeffrey Thomas · CIK 0001617812 · SVP, IP Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,279 Underlying: Common Stock · 49,279 shares Expires 2033-03-24 Read SEC document |
| March 24, 2023 Filed Mar 29, 2023 01:10 UTC |
Perez Jeffrey ThomasSVP, IP Affairs
|
Exercise / conversionRestricted Stock Units · Derivative | 37,756 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-23-004826 · dp191372_4-perez.xml · derivative · entry 3 Perez Jeffrey Thomas · CIK 0001617812 · SVP, IP Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,512 Underlying: Common Stock · 37,756 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F3 · derivative.exercise_date: Represents 1/3 of the RSUs granted on March 24, 2023 that vested immediately. F3 · derivative.expiration_date: Represents 1/3 of the RSUs granted on March 24, 2023 that vested immediately. Read SEC document |
| March 24, 2023 Filed Mar 29, 2023 01:10 UTC |
Perez Jeffrey ThomasSVP, IP Affairs
|
GrantRestricted Stock Units · Derivative | 113,268 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-23-004826 · dp191372_4-perez.xml · derivative · entry 2 Perez Jeffrey Thomas · CIK 0001617812 · SVP, IP Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,268 Underlying: Common Stock · 113,268 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F2 · derivative.exercise_date: 1/3 of the RSUs vested immediately upon the grant date, and the remaining RSUs vest in four equal installments on each of August 2, 2023, August 9, 2023, August 16, 2023 and August 23, 2023. F2 · derivative.expiration_date: 1/3 of the RSUs vested immediately upon the grant date, and the remaining RSUs vest in four equal installments on each of August 2, 2023, August 9, 2023, August 16, 2023 and August 23, 2023. Read SEC document |
| March 24, 2023 Filed Mar 29, 2023 01:10 UTC |
Perez Jeffrey ThomasSVP, IP Affairs
|
Exercise / conversionCommon Stock | 37,756 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-23-004826 · dp191372_4-perez.xml · nonDerivative · entry 1 Perez Jeffrey Thomas · CIK 0001617812 · SVP, IP Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 418,768 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. Read SEC document |
| March 24, 2023 Filed Mar 29, 2023 01:09 UTC |
Lehr Donald P.Chief Legal Officer
|
GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 56,671 | $0.00 Strike: $0.96 | $0.00 |
DisclosureSEC source: 0000950103-23-004825 · dp191371_4-lehr.xml · derivative · entry 4 Lehr Donald P. · CIK 0001583187 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,671 Underlying: Common Stock · 56,671 shares Expires 2033-03-24 Read SEC document |
| March 24, 2023 Filed Mar 29, 2023 01:09 UTC |
Lehr Donald P.Chief Legal Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 43,419 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-23-004825 · dp191371_4-lehr.xml · derivative · entry 3 Lehr Donald P. · CIK 0001583187 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,839 Underlying: Common Stock · 43,419 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F3 · derivative.exercise_date: Represents 1/3 of the RSUs granted on March 24, 2023 that vested immediately. F3 · derivative.expiration_date: Represents 1/3 of the RSUs granted on March 24, 2023 that vested immediately. Read SEC document |
| March 24, 2023 Filed Mar 29, 2023 01:09 UTC |
Lehr Donald P.Chief Legal Officer
|
GrantRestricted Stock Units · Derivative | 130,258 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-23-004825 · dp191371_4-lehr.xml · derivative · entry 2 Lehr Donald P. · CIK 0001583187 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,258 Underlying: Common Stock · 130,258 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F2 · derivative.exercise_date: 1/3 of the RSUs vested immediately upon the grant date, and the remaining RSUs vest in four equal installments on each of August 2, 2023, August 9, 2023, August 16, 2023 and August 23, 2023. F2 · derivative.expiration_date: 1/3 of the RSUs vested immediately upon the grant date, and the remaining RSUs vest in four equal installments on each of August 2, 2023, August 9, 2023, August 16, 2023 and August 23, 2023. Read SEC document |
| March 24, 2023 Filed Mar 29, 2023 01:09 UTC |
Lehr Donald P.Chief Legal Officer
|
Exercise / conversionCommon Stock | 43,419 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-23-004825 · dp191371_4-lehr.xml · nonDerivative · entry 1 Lehr Donald P. · CIK 0001583187 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 385,632 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. Read SEC document |
| March 24, 2023 Filed Mar 29, 2023 01:08 UTC |
Sabzevari HelenDirector · President and CEO
|
GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 369,596 | $0.00 Strike: $0.96 | $0.00 |
DisclosureSEC source: 0000950103-23-004824 · dp191370_4-sabzevari.xml · derivative · entry 4 Sabzevari Helen · CIK 0001724195 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 369,596 Underlying: Common Stock · 369,596 shares Expires 2033-03-24 Read SEC document |
| March 24, 2023 Filed Mar 29, 2023 01:08 UTC |
Sabzevari HelenDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 283,173 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-23-004824 · dp191370_4-sabzevari.xml · derivative · entry 3 Sabzevari Helen · CIK 0001724195 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 566,347 Underlying: Common Stock · 283,173 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F3 · derivative.exercise_date: Represents 1/3 of the RSUs granted on March 24, 2023 that vested immediately. F3 · derivative.expiration_date: Represents 1/3 of the RSUs granted on March 24, 2023 that vested immediately. Read SEC document |
| March 24, 2023 Filed Mar 29, 2023 01:08 UTC |
Sabzevari HelenDirector · President and CEO
|
GrantRestricted Stock Units · Derivative | 849,520 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-23-004824 · dp191370_4-sabzevari.xml · derivative · entry 2 Sabzevari Helen · CIK 0001724195 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 849,520 Underlying: Common Stock · 849,520 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F2 · derivative.exercise_date: 1/3 of the RSUs vested immediately upon the grant date, and the remaining RSUs vest in four equal installments on each of August 2, 2023, August 9, 2023, August 16, 2023 and August 23, 2023. F2 · derivative.expiration_date: 1/3 of the RSUs vested immediately upon the grant date, and the remaining RSUs vest in four equal installments on each of August 2, 2023, August 9, 2023, August 16, 2023 and August 23, 2023. Read SEC document |
| March 24, 2023 Filed Mar 29, 2023 01:08 UTC |
Sabzevari HelenDirector · President and CEO
|
Exercise / conversionCommon Stock | 283,173 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-23-004824 · dp191370_4-sabzevari.xml · nonDerivative · entry 1 Sabzevari Helen · CIK 0001724195 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,220,786 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. Read SEC document |
| March 09, 2023 Filed Mar 13, 2023 17:11 UTC |
KIRK RANDAL JDirector · 10% owner
|
GrantRestricted Stock Units · Derivative | 213,675 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-004946 · doc1.xml · derivative · entry 32 KIRK RANDAL J · CIK 0001091823 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by R.J Kirk DOT Disclosed balance after: 213,675 Underlying: Common Stock · 213,675 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of issuer common stock and (ii) shall vest on the one-year anniversary of the date of grant, subject to Mr. Kirk continuously providing services to the issuer or an affiliate from the date of grant until such time. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one (1) share of issuer common stock and (ii) shall vest on the one-year anniversary of the date of grant, subject to Mr. Kirk continuously providing services to the issuer or an affiliate from the date of grant until such time. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one (1) share of issuer common stock and (ii) shall vest on the one-year anniversary of the date of grant, subject to Mr. Kirk continuously providing services to the issuer or an affiliate from the date of grant until such time. F1 · ownership.nature: Randal J. Kirk controls each of R.J. Kirk Declaration of Trust ("R.J. Kirk DOT"), JPK 2008 LLC ("JPK 2008"), JPK 2009 LLC ("JPK 2009"), JPK 2012 LLC ("JPK 2012"), MGK 2008 LLC ("MGK 2008"), MGK 2009 LLC ("MGK 2009"), MGK 2011 LLC ("MGK 2011"), ZSK 2008 LLC ("ZSK 2008"), ZSK 2009 LLC ("ZSK 2009"), Kellie L. Banks (2009) Long Term Trust ("Kellie L. Banks LTT"), Third Security Senior Staff 2015 LLC ("Sr. Staff 2015"), Third Security Staff 2015 LLC ("Staff 2015"), Parkview 2020 Limited Partnership ("Parkview 2020"), Kapital Joe, LLC ("Kapital Joe"), Lotus Capital (2000) Company, Inc. ("Lotus"), and Sunset 2020 LLC ("Sunset 2020"). Shares held by these entities may be deemed to be beneficially owned (as defined under Rule 13d-3 promulgated under the Securities Exchange Act of 1934, as amended) by Mr. Kirk. Mr. Kirk disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein. Read SEC document |
| March 09, 2023 Filed Mar 13, 2023 17:11 UTC |
KIRK RANDAL JDirector · 10% owner
|
GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 250,978 | $0.00 Strike: $1.17 | $0.00 |
DisclosureSEC source: 0001567619-23-004946 · doc1.xml · derivative · entry 31 KIRK RANDAL J · CIK 0001091823 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by R.J.Kirk DOT Disclosed balance after: 250,978 Underlying: Common Stock · 250,978 shares Expires 2033-03-09 F1 · ownership.nature: Randal J. Kirk controls each of R.J. Kirk Declaration of Trust ("R.J. Kirk DOT"), JPK 2008 LLC ("JPK 2008"), JPK 2009 LLC ("JPK 2009"), JPK 2012 LLC ("JPK 2012"), MGK 2008 LLC ("MGK 2008"), MGK 2009 LLC ("MGK 2009"), MGK 2011 LLC ("MGK 2011"), ZSK 2008 LLC ("ZSK 2008"), ZSK 2009 LLC ("ZSK 2009"), Kellie L. Banks (2009) Long Term Trust ("Kellie L. Banks LTT"), Third Security Senior Staff 2015 LLC ("Sr. Staff 2015"), Third Security Staff 2015 LLC ("Staff 2015"), Parkview 2020 Limited Partnership ("Parkview 2020"), Kapital Joe, LLC ("Kapital Joe"), Lotus Capital (2000) Company, Inc. ("Lotus"), and Sunset 2020 LLC ("Sunset 2020"). Shares held by these entities may be deemed to be beneficially owned (as defined under Rule 13d-3 promulgated under the Securities Exchange Act of 1934, as amended) by Mr. Kirk. Mr. Kirk disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein. Read SEC document |
| March 09, 2023 Filed Mar 13, 2023 17:11 UTC |
KIRK RANDAL JDirector · 10% owner
|
GrantCommon Stock | 85,470 | $1.17 | $99,999.90 |
DisclosureSEC source: 0001567619-23-004946 · doc1.xml · nonDerivative · entry 1 KIRK RANDAL J · CIK 0001091823 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by R.J. Kirk DOT Disclosed balance after: 31,337,786 F1 · ownership.nature: Randal J. Kirk controls each of R.J. Kirk Declaration of Trust ("R.J. Kirk DOT"), JPK 2008 LLC ("JPK 2008"), JPK 2009 LLC ("JPK 2009"), JPK 2012 LLC ("JPK 2012"), MGK 2008 LLC ("MGK 2008"), MGK 2009 LLC ("MGK 2009"), MGK 2011 LLC ("MGK 2011"), ZSK 2008 LLC ("ZSK 2008"), ZSK 2009 LLC ("ZSK 2009"), Kellie L. Banks (2009) Long Term Trust ("Kellie L. Banks LTT"), Third Security Senior Staff 2015 LLC ("Sr. Staff 2015"), Third Security Staff 2015 LLC ("Staff 2015"), Parkview 2020 Limited Partnership ("Parkview 2020"), Kapital Joe, LLC ("Kapital Joe"), Lotus Capital (2000) Company, Inc. ("Lotus"), and Sunset 2020 LLC ("Sunset 2020"). Shares held by these entities may be deemed to be beneficially owned (as defined under Rule 13d-3 promulgated under the Securities Exchange Act of 1934, as amended) by Mr. Kirk. Mr. Kirk disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein. Read SEC document |
| March 09, 2023 Filed Mar 13, 2023 17:10 UTC |
SHAPIRO ROBERT BDirector
|
GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 130,398 | $0.00 Strike: $1.17 | $0.00 |
DisclosureSEC source: 0000950103-23-004012 · dp190525_4-shapiro.xml · derivative · entry 4 SHAPIRO ROBERT B · CIK 0001083227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,398 Underlying: Common Stock · 130,398 shares Expires 2033-03-09 Read SEC document |
| March 09, 2023 Filed Mar 13, 2023 17:10 UTC |
SHAPIRO ROBERT BDirector
|
GrantRestricted Stock Units · Derivative | 53,418 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-23-004012 · dp190525_4-shapiro.xml · derivative · entry 3 SHAPIRO ROBERT B · CIK 0001083227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,418 Underlying: Common Stock · 53,418 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit ('RSU") represents a contingent right to receive one share of Precigen common stock. F4 · derivative.exercise_date: The RSUs vest in full on March 9, 2024. F4 · derivative.expiration_date: The RSUs vest in full on March 9, 2024. Read SEC document |
| March 09, 2023 Filed Mar 13, 2023 17:10 UTC |
SHAPIRO ROBERT BDirector
|
GrantCommon Stock | 26,923 | $1.17 | $31,499.91 |
DisclosureSEC source: 0000950103-23-004012 · dp190525_4-shapiro.xml · nonDerivative · entry 1 SHAPIRO ROBERT B · CIK 0001083227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 329,656 F1 · price: The shares were issued to the reporting person in lieu of an annual retainer of $31,500. Read SEC document |
| March 09, 2023 Filed Mar 13, 2023 21:02 UTC |
Hassan FredDirector
|
GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 125,489 | $0.00 Strike: $1.17 | $0.00 |
DisclosureSEC source: 0000950103-23-004007 · dp190523_4-hassan.xml · derivative · entry 3 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,489 Underlying: Common Stock · 125,489 shares Expires 2033-03-09 Read SEC document |
| March 09, 2023 Filed Mar 13, 2023 21:02 UTC |
Hassan FredDirector
|
GrantRestricted Stock Units · Derivative | 106,837 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-23-004007 · dp190523_4-hassan.xml · derivative · entry 2 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,837 Underlying: Common Stock · 106,837 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ('RSU") represents a contingent right to receive one share of Precigen common stock. F3 · derivative.exercise_date: The RSUs vest in full on March 9, 2024. F3 · derivative.expiration_date: The RSUs vest in full on March 9, 2024. Read SEC document |
| March 09, 2023 Filed Mar 13, 2023 21:02 UTC |
Hassan FredDirector
|
GrantCommon Stock | 48,290 | $1.17 | $56,499.30 |
DisclosureSEC source: 0000950103-23-004007 · dp190523_4-hassan.xml · nonDerivative · entry 1 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308,597 F1 · price: The shares were issued to the reporting person in lieu of an annual retainer of $56,500. Read SEC document |
| March 09, 2023 Filed Mar 13, 2023 21:04 UTC |
KINDLER JEFFREY BDirector
|
GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 125,489 | $0.00 Strike: $1.17 | $0.00 |
DisclosureSEC source: 0000950103-23-004009 · dp190524_4-kindler.xml · derivative · entry 3 KINDLER JEFFREY B · CIK 0001174454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,489 Underlying: Common Stock · 125,489 shares Expires 2033-03-09 Read SEC document |
| March 09, 2023 Filed Mar 13, 2023 21:04 UTC |
KINDLER JEFFREY BDirector
|
GrantRestricted Stock Units · Derivative | 106,837 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-23-004009 · dp190524_4-kindler.xml · derivative · entry 2 KINDLER JEFFREY B · CIK 0001174454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,837 Underlying: Common Stock · 106,837 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F3 · derivative.exercise_date: The RSUs vested in full on March 9, 2024. F3 · derivative.expiration_date: The RSUs vested in full on March 9, 2024. Read SEC document |
| March 09, 2023 Filed Mar 13, 2023 21:04 UTC |
KINDLER JEFFREY BDirector
|
GrantCommon Stock | 58,974 | $1.17 | $68,999.58 |
DisclosureSEC source: 0000950103-23-004009 · dp190524_4-kindler.xml · nonDerivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 334,961 F1 · price: The shares were issued to the reporting person in lieu of an annual retainer of $69,000. Read SEC document |
| March 09, 2023 Filed Mar 13, 2023 17:06 UTC |
Gupta Vinita DDirector
|
GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 125,489 | $0.00 Strike: $1.17 | $0.00 |
DisclosureSEC source: 0000950103-23-004010 · dp190528_4-gupta.xml · derivative · entry 3 Gupta Vinita D · CIK 0001705209 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,489 Underlying: Common Stock · 125,489 shares Expires 2033-03-09 Read SEC document |
| March 09, 2023 Filed Mar 13, 2023 17:06 UTC |
Gupta Vinita DDirector
|
GrantRestricted Stock Units · Derivative | 106,837 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-23-004010 · dp190528_4-gupta.xml · derivative · entry 2 Gupta Vinita D · CIK 0001705209 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,837 Underlying: Common Stock · 106,837 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ('RSU") represents a contingent right to receive one share of Precigen common stock. F3 · derivative.exercise_date: The RSUs vest in full on March 9, 2024. F3 · derivative.expiration_date: The RSUs vest in full on March 9, 2024. Read SEC document |
| March 09, 2023 Filed Mar 13, 2023 17:06 UTC |
Gupta Vinita DDirector
|
GrantCommon Stock | 48,290 | $1.17 | $56,499.30 |
DisclosureSEC source: 0000950103-23-004010 · dp190528_4-gupta.xml · nonDerivative · entry 1 Gupta Vinita D · CIK 0001705209 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,730 F1 · price: The shares were issued to the reporting person in lieu of an annual retainer of $56,500. Read SEC document |
| March 09, 2023 Filed Mar 13, 2023 21:11 UTC |
MITCHELL DEAN JDirector
|
GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 125,489 | $0.00 Strike: $1.17 | $0.00 |
DisclosureSEC source: 0000950103-23-004013 · dp190529_4-mitchell.xml · derivative · entry 3 MITCHELL DEAN J · CIK 0001199297 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,489 Underlying: Common Stock · 125,489 shares Expires 2033-03-09 Read SEC document |
| March 09, 2023 Filed Mar 13, 2023 21:11 UTC |
MITCHELL DEAN JDirector
|
GrantRestricted Stock Units · Derivative | 106,837 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-23-004013 · dp190529_4-mitchell.xml · derivative · entry 2 MITCHELL DEAN J · CIK 0001199297 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,837 Underlying: Common Stock · 106,837 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ('RSU") represents a contingent right to receive one share of Precigen common stock. F3 · derivative.exercise_date: The RSUs vest in full on March 9, 2024. F3 · derivative.expiration_date: The RSUs vest in full on March 9, 2024. Read SEC document |
| March 09, 2023 Filed Mar 13, 2023 21:11 UTC |
MITCHELL DEAN JDirector
|
GrantCommon Stock | 48,290 | $1.17 | $56,499.30 |
DisclosureSEC source: 0000950103-23-004013 · dp190529_4-mitchell.xml · nonDerivative · entry 1 MITCHELL DEAN J · CIK 0001199297 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 331,836 F1 · price: The shares were issued to the reporting person in lieu of an annual retainer of $56,500. Read SEC document |
| March 09, 2023 Filed Mar 13, 2023 21:12 UTC |
Frank StevenDirector
|
GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 125,489 | $0.00 Strike: $1.17 | $0.00 |
DisclosureSEC source: 0000950103-23-004014 · dp190527_4-frank.xml · derivative · entry 3 Frank Steven · CIK 0001583886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,489 Underlying: Common Stock · 125,489 shares Expires 2033-03-09 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.